{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:45:00Z","timestamp":1792687500172,"version":"4.5.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221769","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T17:37:45Z","timestamp":1567100265000},"page":"e0221769","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India"],"prefix":"10.1371","volume":"14","author":[{"given":"Yashika","family":"Chugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha Krishan","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-6986","authenticated-orcid":true,"given":"Shankar","family":"Prinja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Singh Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Bahuguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"issue":"10049","key":"pone.0221769.ref001","first-page":"1081","volume":"388","author":"JD Stanaway","year":"2016","journal-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013"},{"key":"pone.0221769.ref002","author":"World Health Organisation","journal-title":"Burden of Viral Hepatitis in the South-East Asia Region"},{"key":"pone.0221769.ref003","volume-title":"WHO GoI-ILBS National Technical Consultation on Viral Hepatitis\u2014\u201cTowards a National Action Plan for Viral Hepatitis (NAP-VH)","author":"Government of India, World Health Organisation, Institute of Liver and Biliary Sciences","year":"2016"},{"issue":"4","key":"pone.0221769.ref004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12038-008-0065-0","article-title":"Hepatitis C in India","volume":"33","author":"A Mukhopadhya","year":"2008","journal-title":"J Biosci"},{"issue":"SUPPL. 2","key":"pone.0221769.ref005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","article-title":"A systematic review of hepatitis C virus epidemiology in Asia","volume":"31","author":"W Sievert","year":"2011","journal-title":"Australia and Egypt. Liver Int"},{"issue":"2","key":"pone.0221769.ref006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jceh.2014.05.006","article-title":"Consensus statement of HCV task force of the Indian National Association for Study of the Liver (INASL). Part I: Status report of HCV infection in India","volume":"4","author":"P Puri","year":"2014","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"pone.0221769.ref007","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jceh.2016.09.005","article-title":"Tackling the Hepatitis C Disease Burden in Punjab, India","volume":"6","author":"R Dhiman","year":"2016","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"pone.0221769.ref008","doi-asserted-by":"crossref","first-page":"e0200461","DOI":"10.1371\/journal.pone.0200461","article-title":"The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey","volume":"13","author":"A Sood","year":"2018","journal-title":"PLoS ONE"},{"key":"pone.0221769.ref009","volume-title":"Global hepatitis report","author":"World Health Organization","year":"2017"},{"issue":"12","key":"pone.0221769.ref010","first-page":"1226","article-title":"Review Article Update of old and emerging therapies in chronic hepatitis C","volume":"61","author":"SI Haider","year":"2011","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"pone.0221769.ref011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jceh.2017.08.003","article-title":"Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?","volume":"7","author":"M Premkumar","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"pone.0221769.ref012","volume-title":"Mukh Mantri Punjab Hepatitis-C Relief Fund (MMPHCRF)-One Year Journey","author":"Government of Punjab","year":"2017"},{"key":"pone.0221769.ref013","unstructured":"National Guidelines for Diagnosis & Management of Viral Hepatitis [Internet]. Inasl.org.in. 2018 [cited 13 November 2018]. Available from: https:\/\/www.inasl.org.in\/diagnosis-management-viral-hepatitis.pdf"},{"key":"pone.0221769.ref014","unstructured":"Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection [Internet]. Apps.who.int. 2018 [cited 13 November 2018]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273174\/9789241550345-eng.pdf?ua=1"},{"issue":"2","key":"pone.0221769.ref015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12072-016-9776-8","article-title":"Sofosbuvir\/velpatasvir: a pangenotypic drug to simplify HCV therapy","volume":"11","author":"R Lee","year":"2017","journal-title":"Hepatol Int"},{"issue":"27","key":"pone.0221769.ref016","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection","volume":"373","author":"JJ Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0221769.ref017","volume-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"World Health Organization","year":"2003"},{"issue":"17","key":"pone.0221769.ref018","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/cncr.30734","article-title":"Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program","volume":"123","author":"S Prinja","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"pone.0221769.ref019","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40258-015-0201-6","article-title":"Systematic Review of the State of Economic Evaluation for Health Care in India","volume":"13","author":"S Prinja","year":"2015","journal-title":"AApplied Health Economics and Health Policy"},{"key":"pone.0221769.ref020","volume-title":"Health Technology Assessment in India","author":"Department of Health Research","year":"2018"},{"key":"pone.0221769.ref021","author":"World Health Organisation","journal-title":"Viral hepatitis C treatment in India"},{"issue":"2","key":"pone.0221769.ref022","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"P Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"pone.0221769.ref023","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jvh.12350","article-title":"Historical epidemiology of hepatitis C virus (HCV) in select countries\u2014volume 2","volume":"22","author":"V Saraswat","year":"2015","journal-title":"Journal of Viral Hepatitis"},{"key":"pone.0221769.ref024","first-page":"1","article-title":"Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India","author":"S Prinja","year":"2017","journal-title":"PharmacoEconomics\u2014Open"},{"issue":"6","key":"pone.0221769.ref025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4103\/ijmr.IJMR_2003_15","article-title":"Out-of-pocket expenditure for hospitalization in Haryana State of India: Extent, determinants & financial risk protection","volume":"146","author":"S Prinja","year":"2017","journal-title":"Indian Journal of Medical Research"},{"issue":"8","key":"pone.0221769.ref026","doi-asserted-by":"crossref","first-page":"0160986","DOI":"10.1371\/journal.pone.0160986","article-title":"Cost of Delivering Health Care Services in Public Sector Primary and Community Health Centres in North India","volume":"11","author":"S Prinja","year":"2016","journal-title":"PLOS ONE"},{"key":"pone.0221769.ref027","author":"G Kaur","year":"2018","journal-title":"Cost of Treatment of Multiple Myeloma in a Public Sector Tertiary Care Hospital of North India"},{"key":"pone.0221769.ref028","article-title":"Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective","author":"RK Dhiman","year":"2018","journal-title":"J Pediatric Gastroenterol Nutrition"},{"key":"pone.0221769.ref029","unstructured":"XE: Convert USD\/INR. United States Dollar to India Rupee [Internet]. Xe.com. 2018 [cited 20 December 2018]. Available from: https:\/\/www.xe.com\/currencyconverter\/convert\/?Amount=1&From=USD&To=INR"},{"key":"pone.0221769.ref030","volume-title":"Key Indicators of Social Consumption in India: Health (NSSO 71st Round, January\u2013June 2014)","author":"National Sample Survey Office","year":"2015"},{"issue":"8","key":"pone.0221769.ref031","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jval.2011.06.005","article-title":"Estimating Population-Based Values for EQ-5D Health States in Thailand","volume":"14","author":"S Tongsiri","year":"2011","journal-title":"Value in Health"},{"key":"pone.0221769.ref032","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1111\/j.1572-0241.2003.07332.x","article-title":"Healthstate utilities and quality of life in hepatitis C patients","volume":"98","author":"CA Chong","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"pone.0221769.ref033","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression","volume":"48","author":"H Thein","year":"2008","journal-title":"Hepatology"},{"issue":"24","key":"pone.0221769.ref034","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis","volume":"308","author":"A Van der Meer","year":"2012","journal-title":"JAMA"},{"key":"pone.0221769.ref035","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"GR Foster","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0221769.ref036","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"\u2019Leary JG, Bzowej N. Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"JO Curry MP","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0221769.ref037","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jceh.2018.06.299","article-title":"8. Experience of sofosbuvir\/velpatasvir based combination therapy for chronic hepatitis C genotype 3 patients from real life western Indian population","volume":"8","author":"S Bherwani","year":"2018","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"5","key":"pone.0221769.ref038","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2004.01.005","article-title":"Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients","volume":"40","author":"R Planas","year":"2004","journal-title":"Journal of Hepatology"},{"issue":"1","key":"pone.0221769.ref039","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"G D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"9","key":"pone.0221769.ref040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005","volume":"27","author":"S Altekruse","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"pone.0221769.ref041","author":"Registrar General & Census Commissioner of India","journal-title":"SRS life tables 2011\u20132015"},{"key":"pone.0221769.ref042","article-title":"Cost-effectiveness of generic pan-genotypic sofosbuvir\/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment","author":"A Goel","year":"2018","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"pone.0221769.ref043","volume-title":"Report on Macroeconomics and Health: Investing in Health for Economic Development","author":"Commission on Macroeconomics and Health of WHO","year":"2001"},{"key":"pone.0221769.ref044","volume-title":"Centre for Health Economics","author":"P Revill","year":"2015"},{"issue":"1","key":"pone.0221769.ref045","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-015-0043-8","article-title":"Availability of medicines in public sector health facilities of two North Indian States","volume":"16","author":"S Prinja","year":"2015","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"4","key":"pone.0221769.ref046","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0970-0218.193344","article-title":"Towards a better health care delivery system: The Tamil Nadu model","volume":"41","author":"R Parthasarathi","year":"2016","journal-title":"Indian Journal of Community Medicine"},{"key":"pone.0221769.ref047","unstructured":"Sofosbuvir + velpatasvir: view uses, side effects and medicines | 1mg [Internet]. 1mg.com. 2018 [cited 12 October 2018]. Available from: https:\/\/www.1mg.com\/generics\/sofosbuvir-velpatasvir-405072?q=sofosbu"},{"issue":"8","key":"pone.0221769.ref048","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jval.2017.05.003","article-title":"Utility of Elbasvir\/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection","volume":"20","author":"S Corman","year":"2017","journal-title":"Value in Health"},{"issue":"5","key":"pone.0221769.ref049","doi-asserted-by":"crossref","first-page":"0176503","DOI":"10.1371\/journal.pone.0176503","article-title":"Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India","volume":"12","author":"R Aggarwal","year":"2017","journal-title":"PLOS ONE"},{"issue":"4","key":"pone.0221769.ref050","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis","volume":"51","author":"G Garcia-Tsao","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"pone.0221769.ref051","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2004.07.003","article-title":"Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India","volume":"32","author":"S Chaudhuri","year":"2005","journal-title":"Journal of Clinical Virology"},{"issue":"4","key":"pone.0221769.ref052","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jhep.2003.50157","article-title":"Hepatitis C virus infection in the general population: A community-based study in West Bengal","volume":"37","author":"A Chowdhury","year":"2003","journal-title":"India. Hepatology"},{"issue":"6","key":"pone.0221769.ref053","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40258-018-0416-4","article-title":"Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates","volume":"16","author":"J Pike","year":"2018","journal-title":"A Review. Applied Health Economics and Health Policy"},{"issue":"3","key":"pone.0221769.ref054","doi-asserted-by":"crossref","first-page":"e1002759","DOI":"10.1371\/journal.pmed.1002759","article-title":"The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance","volume":"16","author":"B Angell","year":"2019","journal-title":"PLOS Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:10:56Z","timestamp":1588990256000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221769"}},"subtitle":[],"editor":[{"given":"Sukumar","family":"Vellakkal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221769","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]}}}